Connect your AI

Veeva Systems VEEV Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

Charles River LaboratoriesCRL

$208.29M-41.0%

IQVIAIQV

——

RevvityRVTY

——

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

Revenue$882.9M+16.3%

Gross profit$662.0M+13.1%

Operating income$273.1M+16.8%

Net income$260.9M+14.4%

EPS (diluted)$1.57+14.6%

Balance sheet

Cash & equivalents$1.9B-3.5%

Total debt$103.1M+33.5%

Total equity$7.3B+17.6%

Total assets$9.1B+17.6%

Cash flow

Operating cash flow$1.1B+28.5%

CapEx$2.3M—

Free cash flow$110.6M—

Valuation

Market cap$32.68B-30.4%

Enterprise value$30.89B-31.4%

P/E34.7×-25.4×

P/S9.9×-6.6×

Profitability

Gross margin75%-0.5pp

Operating margin28.8%+1.8pp

Net margin28.4%+1.0pp

FCF margin37.2%—

Returns & leverage

Return on equity13.9%-0.1pp

Debt / equity0×0.0×

Current ratio4.7×+0.1×

Where this comes from

Reported directly by Veeva Systems in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Veeva Systems’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veeva Systems's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Veeva Systems's payments for repurchase of common stock?: Veeva Systems (VEEV) reported payments for repurchase of common stock of $226.95M in Q1 2026.